Danazol for uterine fibroids.

Author: KeLin-Qiu, LiChun-Mei, LiJing, YangKun

Paper Details 
Original Abstract of the Article :
BACKGROUND: Uterine fibroids (myomas, fibromyomas, leiomyomas) are the most common benign tumours of the female genital tract. Danazol, a synthetic isoxazole derivative chemically related to 17-ethinyl testosterone, has been used for many years for the treatment of women with uterine fibroids. OBJE...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7188078/

データ提供:米国国立医学図書館(NLM)

The Unexplored Desert: Danazol for Uterine Fibroids

Uterine fibroids, a common benign tumor, can cause a range of symptoms, including heavy bleeding and pelvic pain. This study, like a desert explorer venturing into uncharted territory, seeks to understand the effectiveness and safety of danazol, a synthetic hormone, in treating uterine fibroids. Despite its widespread use, the researchers found a surprising lack of reliable evidence from randomized controlled trials to support its efficacy and safety. This underscores the need for rigorous scientific investigation to ensure that treatments are both effective and safe. The study calls for further research to fill this knowledge gap and provide evidence-based guidance for clinicians.

A Need for Evidence: Guiding Treatment Decisions

This study highlights the critical need for robust scientific evidence to guide treatment decisions. Just as a desert traveler relies on a reliable map to navigate unfamiliar terrain, clinicians need evidence-based data to ensure they are providing the best possible care for their patients. The absence of reliable evidence for danazol's effectiveness in treating uterine fibroids underscores the importance of conducting well-designed clinical trials to address these knowledge gaps.

The Desert of Uncertainty: Navigating with Caution

This study serves as a reminder that the world of medicine, like a vast desert, can hold many unknowns. While danazol has been used to treat uterine fibroids for many years, the lack of reliable evidence about its efficacy and safety necessitates a cautious approach. Clinicians must carefully weigh the potential benefits and risks of this treatment option and consider alternative therapies when possible.

Dr.Camel's Conclusion

This study, like a compass pointing towards a horizon shrouded in mist, highlights the need for continued research and critical evaluation in medicine. The lack of reliable evidence for danazol's effectiveness in treating uterine fibroids underscores the importance of rigorous scientific investigation to ensure that treatments are both effective and safe.

Date :
  1. Date Completed 2009-08-14
  2. Date Revised 2021-10-20
Further Info :

Pubmed ID

19588442

DOI: Digital Object Identifier

PMC7188078

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.